Pebblebrook Hotel (PEB) Shares Upgraded by RBC Capital (RY) to "Outperform" - LocalizedUSA

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!

Pebblebrook Hotel (NYSE: PEB) was upgraded by equities research analysts at RBC Capital (NYSE: RY) from a "sector perform" rating to an "outperform" rating in a research note issued to investors on Thursday. They currently have a $19.00 price target on the company's shares, down from $22.00.

Separately, analysts at Zacks Investment Research downgraded shares of Pebblebrook Hotel from an "outperform" rating to a "neutral" rating in a research note to investors on Monday.

Pebblebrook Hotel Trust is an internally managed hotel investment company, organized to acquire and invest in hotel properties located in the cities of the United States. As of March 24, 2010, the Company did not own any properties. The assets of the Company are held by, and all of the operations would be conducted through Pebblebrook Hotel L.P. (the Operating Partnership). At December 31, 2009, the Company owned 100% of the Operating Partnership. In June 2010, Pebblebrook Hotel Trust acquired the Doubletree Bethesda Hotel and Executive Meeting Center. In June 2010, the Company acquired the Sir Francis Drake Hotel. In September 2010, the Company acquired The Grand Hotel Minneapolis.

Shares of Pebblebrook Hotel traded up 4.68% during mid-day trading on Thursday, hitting $15.179. Pebblebrook Hotel has a 52 week low of $14.05 and a 52 week high of $22.47. The stock's 50-day moving average is $16.10 and its 200-day moving average is $19.63. The company has a market cap of $772.6 million.

Stay on top of analysts' coverage with our daily email newsletter that provides a concise list of analysts' upgrades, analysts' downgrades and analysts' price target changes for each day. Click here to register.